Clinical Trial Update: A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study assessed the safety and efficacy of Bavituximab in combination with docetaxel in patients with advanced breast cancer, and the trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bavituximab (bavituximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Peregrine Pharmaceuticals | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED